These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 27092777)
1. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer. Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777 [TBL] [Abstract][Full Text] [Related]
2. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer. Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510 [TBL] [Abstract][Full Text] [Related]
3. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer. Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713 [TBL] [Abstract][Full Text] [Related]
4. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852 [TBL] [Abstract][Full Text] [Related]
6. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
7. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Xu YZ; Xi QH; Ge WL; Zhang XQ Asian Pac J Cancer Prev; 2013; 14(2):1057-60. PubMed ID: 23621186 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. Hong F; Li Y; Xu Y; Zhu L J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131 [TBL] [Abstract][Full Text] [Related]
9. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653 [TBL] [Abstract][Full Text] [Related]
10. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses. Chen Z; Guo X; Sun S; Lu C; Wang L Bioengineered; 2020 Dec; 11(1):311-317. PubMed ID: 32107956 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
13. The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients. Zuberi M; Mir R; Khan I; Javid J; Guru SA; Bhat M; Sumi MP; Ahmad I; Masroor M; Yadav P; Vishnubhatla S; Saxena A Microrna; 2020; 9(1):49-57. PubMed ID: 30799804 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein. Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Wang S; Zhao X; Wang J; Wen Y; Zhang L; Wang D; Chen H; Chen Q; Xiang W Med Oncol; 2013; 30(3):681. PubMed ID: 23918241 [TBL] [Abstract][Full Text] [Related]
17. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
18. Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women. Habel A; Nassar F; Itani M; Bouaziz H; Hadj-Ahmed M; Msheik Z; Stayoussef M; Nasr R; Yacoubi-Loueslati B Afr Health Sci; 2023 Jun; 23(2):256-264. PubMed ID: 38223583 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1. Jin M; Yang Z; Ye W; Xu H; Hua X PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Peng DX; Luo M; Qiu LW; He YL; Wang XF Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]